LSL PHARMA DISTRIBUTION

Serial Number 79382395
Registration 7699738
700

Registration Progress

Application Filed
May 24, 2023
Under Examination
Approved for Publication
Jan 7, 2025
Published for Opposition
Jan 7, 2025
Registered
Feb 25, 2025

Basic Information

Serial Number
79382395
Registration Number
7699738
Filing Date
May 24, 2023
Registration Date
February 25, 2025
Published for Opposition
January 7, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 25, 2025
Registration
Registered
Classes
035 039

Rights Holder

R.G.C.C. Holdings AG

25
Address
Baarerstrasse 95
CH-6300 Zug
CH

Ownership History

R.G.C.C. Holdings AG

Original Applicant
25
CH

R.G.C.C. Holdings AG

Owner at Publication
25
CH

R.G.C.C. Holdings AG

Original Registrant
25
CH

Legal Representation

Attorney
James R. Menker

USPTO Deadlines

Next Deadline
2058 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-25)
Due Date
February 25, 2031
Grace Period Ends
August 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description
Jun 24, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 24, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 25, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 21, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 21, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2024 PETG O PETITION TO REVIVE-GRANTED
Oct 21, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED
Oct 21, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2024 RFNT P REFUSAL PROCESSED BY IB
Apr 6, 2024 RFRR P REFUSAL PROCESSED BY MPU
Apr 6, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 19, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2024 CNRT R NON-FINAL ACTION WRITTEN
Mar 4, 2024 CREV I CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Feb 14, 2024 DOCK D ASSIGNED TO EXAMINER
Jan 29, 2024 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB
Nov 7, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Nov 3, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 035
Advertising services; commercial business management; commercial administration of the licensing of the goods and services of others; Providing office functions
Class 039
Transport, in particular delivery of medicines in the framework of a mail-order pharmacy and in the framework of a pharmaceutical wholesale trade; packaging and storage of merchandise for others

Additional Information

Design Mark
The mark consists of a blue shield with a white cross, the wording "LSL" in blue, and the wording "PHARMA DISTRIBUTION" in light gray.
Color Claim
The color(s) blue, light gray and white is/are claimed as a feature of the mark.

Classification

International Classes
035 039

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA DISTRIBUTION"